JERASH HOLDINGS US INC (JRSH)       5.85  +0.07 (+1.21%)

5.85  +0.07 (+1.21%)

US47632P1012 - Common Stock


Fundamental Rating

We assign a fundamental rating of 7 out of 10 to JRSH. JRSH was compared to 48 industry peers in the Textiles, Apparel & Luxury Goods industry. JRSH has a great financial health rating, but there are some minor concerns on its profitability. JRSH has both an excellent growth and valuation score. This means it is growing and it is still cheap. This is a rare combination!




Profitability

Profitability Rating


JRSH has a Return On Assets of 9.28%. This is better than the industry average of 7.06%.
The Piotroski-F score of JRSH is 8.00. This is a very strong score and indicates great health and profitability for JRSH.

JRSH's Return On Equity of 11.43% is worse than the rest of the industry. The industry average Return On Equity is 21.91%.
JRSH's Profit Margin of 5.52% is worse than the rest of the industry. The industry average Profit Margin is 7.04%.
VS Industry

ROA (9.28%) VS Industry: 61% outperformed.

-97.69
21.72

ROE (11.43%) VS Industry: 27% outperformed.

2.52
115.04

Profit Margin (5.52%) VS Industry: 40% outperformed.

-118.54
24.62

Valuation

Valuation Rating


The Price/Earnings Ratio is 8.60, which indicates a very decent valuation of JRSH.
JRSH's Price/Earning Ratio is a bit cheaper than the industry average which is at 10.58.
With a Forward Price/Earnings Ratio of 6.83, the valuation of JRSH can be described as cheap.
The low PEG Ratio, which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.

Compared to an average industry price book ratio of 2.75, JRSH is valued rather cheaply
When comparing the Enterprise Value to EBITDA ratio of JRSH to the average industry ratio of 7.79, JRSH is valued rather cheaply. JRSH is also cheaper than 97% of the companies listed in the same industry.
When comparing the current price to the book value of JRSH, we can conclude it is valued correctly. It is trading at 1.04 times its book value.
VS Industry

Price/Earnings (8.6) VS Industry: 69% outperformed.

39.32
3.80

Price/Book (1.04) VS Industry: 65% outperformed.

15.27
0.15

Enterprise Value/ EBITDA (1.68) VS Industry: 97% outperformed.

204.18
0.16

Growth

Growth Rating


The Earnings Per Share has grown by an impressive 83.78% over the past year.
The Earnings Per Share is expected to grow by 31.70% on average over the next 5 years. This is a very strong growth
The EPS growth is accelerating: in the next 5 years the growth will be better than in the last years.
The Revenue has grown by 58.90% in the past year. This is a very strong growth!

Measured over the past 5 years, JRSH shows a quite strong growth in Revenue. The Revenue has been growing by 18.24% on average per year.
Based on estimates for the next 5 years, JRSH will show a quite strong growth in Revenue. The Revenue will grow by 14.53% on average per year.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming 5 years, we see that the growth is stable.
The earnings per share for JRSH have been decreasing by -11.36% on average. This is quite bad

PastFuture
5Y3Y1Y1Y2Y3Y5Y
EPS-11.36% 2.58% 83.78% 26% 35.83% 32.62% 31.7%
Revenue18.24% 19.04% 58.9% 9.07% 15.02% 14.32% 14.53%

Health

Health Rating


JRSH has a Current Ratio of 4.94. This indicates that JRSH is financially healthy and has no problem in meeting its short term obligations.
The Current Ratio of JRSH is much better than the industry average of 2.34. JRSH has a better rating than 93% of its industry peers.
A Quick Ratio of 2.94 indicates that JRSH has no problem at all paying its short term obligations.
JRSH is one of the better placed companies in its industry to meet its short term obligations. Its Current Ratio is much better than the industry average of 1.28. JRSH has a better rating than 89% of its industry peers.

When comparing the Debt to Equity Ratio of 0.00 to an average industry Debt to Equity of 0.39, JRSH is way less dependent on financing that its industry peers.
JRSH has an Altman-Z score of 6.21. This indicates that JRSH is financially healthy and little risk of bankruptcy at the moment.
JRSH has one of the better Altman-Z scores in its industry. It is much better than the industry average of 3.20. JRSH has a better score than 84% of its industry peers.
The Piotroski-F score of JRSH is 8.00. This is a very strong score and indicates great health and profitability for JRSH.
VS Industry

Debt/Equity (0) VS Industry: 63% outperformed.

5.58
-0.54

Quick Ratio (2.94) VS Industry: 89% outperformed.

0.09
4.92

Current Ratio (4.94) VS Industry: 93% outperformed.

0.46
8.36

Altman-Z (6.21) VS Industry: 84% outperformed.

-54.92
15.14

Dividend

Dividend Rating


Compared to an average industry Dividend Yield of 2.99, JRSH pays a bit more dividend than its industry peers.
JRSH's Dividend Yield is a higher than the S&P500 average which is at 2.39.
The dividend of JRSH is nicely growing with an annual growth rate of 25.99%!
JRSH's earnings are growing more than its dividend. This makes the dividend growth sustainable.

JRSH pays out 29.89% of its income as dividend. This is a sustainable payout ratio.
JRSH has a Yearly Dividend Yield of 3.58%. Purely for dividend investing, there may be better candidates out there.
JRSH has been paying a dividend for less than 5 years, so it still needs to build a track record.
VS Industry

Dividend Yield (3.58%) VS Industry: 66% outperformed.

0.24
9.26
JRSH Daily chart

JERASH HOLDINGS US INC5.85

NASDAQ:JRSH (8/10/2022, 7:00:02 PM)+0.07 (+1.21%)

Chartmill FA Rating
GICS Sector Consumer Discretionary
GICS IndustryGroup Consumer Durables & Apparel
GICS Industry Textiles, Apparel & Luxury Goods
Earnings (Last) 08-09 2022-08-09 Earnings (Next) 11-08 2022-11-08
Ins Owners 15.43% Inst Owners 3.8%
Market Cap 72.16M Analysts 82.22
Valuation
PE 8.6 Fwd PE 6.83
PEG (NY) 0.33 PEG (5Y) N/A
P/S 0.5 P/B 1.04
EV/EBITDA 1.68
Profitability
ROA 9.28% ROE 11.43%
PM 5.52 Asset Turnover 1.68
Growth
EPS 1Y 83.78% EPS 3Y 2.58%
EPS 5Y -11.36% EPS growth Q2Q -116.67%
EPS Next Y 26% EPS Next 2Y 35.83%
EPS Next 3Y 32.62% EPS Next 5Y 31.7%
Revenue growth 1Y 58.9% Revenue growth 3Y 19.04%
Revenue growth 5Y 18.24% Revenue growth Q2Q 30.24%
Revenue Next Year 9.07% Revenue Next 2Y 15.02%
Revenue Next 3Y 14.32% Revenue Next 5Y 14.53%
Health
Current Ratio 4.94 Quick Ratio 2.94
Altman-Z 6.21 F-Score 8
Debt/Equity N/A
Dividend
Dividend Yield 3.58% Dividend Growth 25.99%
DP 29.89% Ex-Date 08-16 2022-08-16 (0.05)

Fundamental Stock Screener Links

Screen Image

Fundamental Stock Screener

Find stocks with similar Fundamental rating on the USA

Screen Image

Growth Stock Screener

Find more growth stocks the USA

Screen Image

Best Fundamental Competitors Stock Screener

Find the competitors with the best fundamentals on the USA

Screen Image

Best Valuation Competitors Stock Screener

Find the competitors with the best valuation on the USA

Screen Image

Best Dividend Competitors Stock Screener

Find the competitors with the best dividend on the USA